COVID-19, it is a novel coronavirus with new strain that has not been previously identified in humans, belongs to Coronaviruses (CoV) such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

 

Specification

  • Fast Reaction: 15 minutes
  • Positive Coincident Rate: ≥82%
  • Negative Coincident Rate: ≥96% SPECIFICATION
  •  Note: Results compared to Molecular testing.

 

Intended Use
Used for the qualitative detection of the antibody IgM to novel Coronavirus (COVID-19) in human serum/ plasma/whole blood.

 

Test Principle
When the sample contains the COVID-19 IgM antibody, it forms a complex with the gold label antigen (COVID-19 recombinant antigen). The complex moves forward under the action of chromatography and combines with the coated antibody (Mouse anti-human IgM monoclonal antibody) at the T line to form a complex and develop color (T line), which is a positive result. When the sample does not contain the COVID-19 IgM antibody, no complex can be formed at the T line, and no red band appears, which is a negative result.

 

Test Procedure and Read result

See picture 2.

Novel Corona Virus (COVID-19) IgM Ab Rapid Test

Artikelnummer: CM00200
14,30 €Preis
  • In this trial, 1300 clinical samples were selected. There were 300 positive samples and 1000 negative samples.

    The COVID-19 IgM Ab rapid test and the COVID-19 nucleic acid reagent were detected simultaneously, and the positive coincidence rate, negative coincidence rate, and total coincidence rate were calculated.

Contact:

Zur Herrgottsruhe 54

89335 Ichenhausen Germany

Pan.Li@commomed.com

Tel: +49-176 / 78816123

Folgen Sie uns Social Media damit wir Sie über die neusten Produkte informieren können:

  • Facebook

 © 2020 CommoMed